Inventor · disambiguated record
Dilara Mccauley
Also filed as: MCCAULEY DILARA
44 granted patents·14 pending applications·592 citations·filing 2005–2023
98Inventor score
Files withKARYOPHARM THERAPEUTICS INC27ARCHEMIX LLC6BIOGEN MA INC6EPIX PHARM INC4SANDANAYAKA VINCENT P3
Top patents by PatentIndex Score
58 records- 0198US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0297US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0397US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0497US10335393B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·20 cites·12 claims
- 0597US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 0697US10058535B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Aug 28, 2018·24 cites·1 claims
- 0797US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 0897US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 0997US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1097US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1197US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1297US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1397US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1496US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1596US9079865B2Hydrazide containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Jul 14, 2015·38 cites·13 claims
- 1695US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 1795US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 1894US10722497B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2019·Granted Jul 28, 2020·3 cites·26 claims
- 1994US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 2093US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 2192US10617677B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2018·Granted Apr 14, 2020·3 cites·18 claims
- 2292US10202366B2Methods of promoting wound healing using CRM1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Feb 12, 2019·22 cites·6 claims
- 2392US9428490B2Nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Aug 30, 2016·27 cites·8 claims
- 2492US9303000B2Olefin containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Apr 5, 2016·28 cites·10 claims
- 2592US7579456B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2006·Granted Aug 25, 2009·24 cites·6 claims
- 2688US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2788US8236773B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2006·Granted Aug 7, 2012·9 cites·10 claims
- 2888US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 2987US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 3087US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 3187US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 3286US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 3386US8436164B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2012·Granted May 7, 2013·6 cites·15 claims
- 3485US10925859B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2020·Granted Feb 23, 2021·1 cites·21 claims
- 3584US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 3683US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3782US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3878US11318120B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2021·Granted May 3, 2022·0 cites·6 claims
- 3977US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 4077US7855193B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2006·Granted Dec 21, 2010·3 cites·11 claims
- 4175US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 4274US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 4372US8569259B2Adenosine analogs and their useBEN-ZEEV EFRAT·Filed 2007·Granted Oct 29, 2013·2 cites·21 claims
- 4472US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4563US2020087313A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4663US2015140120A1Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsARCHEMIX LLC·Filed 2014·Application pending·0 cites
- 4762US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 4858US9255121B2Adenosine analogs and their useMICRODOSE THERAPEUTX INC·Filed 2013·Granted Feb 9, 2016·0 cites·16 claims
- 4957US8853376B2Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsMCCAULEY DILARA·Filed 2011·Granted Oct 7, 2014·0 cites·9 claims
- 5057US2017137430A1Nuclear Transport Modulators And Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dilara Mccauley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →